1. Home
  2. EXEL vs UFPI Comparison

EXEL vs UFPI Comparison

Compare EXEL & UFPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • UFPI
  • Stock Information
  • Founded
  • EXEL 1994
  • UFPI 1955
  • Country
  • EXEL United States
  • UFPI United States
  • Employees
  • EXEL N/A
  • UFPI N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • UFPI Forest Products
  • Sector
  • EXEL Health Care
  • UFPI Basic Materials
  • Exchange
  • EXEL Nasdaq
  • UFPI Nasdaq
  • Market Cap
  • EXEL 10.0B
  • UFPI 8.1B
  • IPO Year
  • EXEL 2000
  • UFPI 1993
  • Fundamental
  • Price
  • EXEL $34.59
  • UFPI $122.17
  • Analyst Decision
  • EXEL Buy
  • UFPI Strong Buy
  • Analyst Count
  • EXEL 17
  • UFPI 4
  • Target Price
  • EXEL $32.18
  • UFPI $148.00
  • AVG Volume (30 Days)
  • EXEL 1.7M
  • UFPI 215.0K
  • Earning Date
  • EXEL 02-04-2025
  • UFPI 10-28-2024
  • Dividend Yield
  • EXEL N/A
  • UFPI 1.08%
  • EPS Growth
  • EXEL 441.02
  • UFPI N/A
  • EPS
  • EXEL 1.55
  • UFPI 7.26
  • Revenue
  • EXEL $2,081,598,000.00
  • UFPI $6,714,661,000.00
  • Revenue This Year
  • EXEL $20.59
  • UFPI N/A
  • Revenue Next Year
  • EXEL $1.50
  • UFPI $3.34
  • P/E Ratio
  • EXEL $22.41
  • UFPI $16.80
  • Revenue Growth
  • EXEL 17.31
  • UFPI N/A
  • 52 Week Low
  • EXEL $19.20
  • UFPI $107.49
  • 52 Week High
  • EXEL $36.97
  • UFPI $141.33
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 51.61
  • UFPI 32.57
  • Support Level
  • EXEL $34.30
  • UFPI $129.07
  • Resistance Level
  • EXEL $36.22
  • UFPI $132.78
  • Average True Range (ATR)
  • EXEL 0.75
  • UFPI 2.67
  • MACD
  • EXEL -0.29
  • UFPI -1.47
  • Stochastic Oscillator
  • EXEL 25.09
  • UFPI 0.00

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About UFPI UFP Industries Inc.

UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction.

Share on Social Networks: